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The topic of male circumcision (MC) is of considerable current interest, largely because of 
widespread publicity generated by research findings attesting to its ability to prevent HIV 
infection during heterosexual intercourse. In addition, its long-recognized ability to protect 
against other sexually transmitted infections (STIs) has also been well publicized in recent 
times, especially now that support has been provided by large randomized controlled trials 
(RCTs). 
While MC can be performed at any age, the ease with which circumcision can be performed 
in infancy makes this time of life preferable to intervention later in childhood or in 
adulthood. As well as the issue of safety, convenience, simplicity and consequent cost 
reductions, circumcision in infancy provides greater net benefits over the lifetime of the 
individual.  
It provides immediate 10-fold protection against urinary tract infections and thus kidney 
damage in baby boys, and greater protection against penile cancer than circumcision later in 
life, virtually eliminating the risk of this disease with its high morbidity and mortality (Morris, 
2007; Morris, 2010; Tobian et al., 2010; Morris et al., 2011). Another benefit is prevention of 
phimosis, a common cause of sexual problems in adolescent boys and men, and a major risk 
factor for penile cancer. It also lowers to risk of inflammatory skin conditions such as 
balanoposthitis. Circumcised men have superior hygiene (O'Farrell et al., 2005) and half the 
prevalence of thrush (Richters et al., 2006). As far as protection against STIs is concerned, the 
most notable is human papillomavirus (HPV), the pathogen not only responsible for most 
cervical cancers in women, but also a proportion of penile cancers in men (Morris et al., 2011). 
MC also reduces the incidence of ulcerative STIs, including syphilis, chancroid, Trichomonas 
vaginalis, and herpes simplex virus type 2 (HSV-2) (Weiss et al., 2006; Morris & Castellsague, 
2010; Tobian et al., 2010). Circumcised men have lower genital ulcer disease as a result of this 
and the reduction in penile injury arising from tearing of the foreskin and frenulum during 
sexual activity (Bailey & Mehta, 2009). MC reduces sexual problems with age and diabetes 
(Morris, 2007; Morris, 2010; Tobian et al., 2010; Morris et al., 2011), and has no adverse effect on 
sexual function, sensation or acceptability (Morris, 2007; Tobian et al., 2010), if anything the 
reverse (Krieger et al., 2008). MC provides a public health benefit to women by lowering their 
risk of various STIs, including high-risk HPV types that cause cervical cancer, HSV-2, 
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Chlamydia trachomatis that can cause pelvic inflammatory disease, ectopic pregnancy and 
infertility, as well reducing the risk of bacterial vaginosis (Morris, 2007; Morris, 2010; Tobian et 
al., 2010; Morris et al., 2011; Wawer et al., 2011). 
If one tallies up all of the conditions listed above, 1 in 3 uncircumcised men will require 
medical attention from a condition stemming from their uncircumcised state (Morris, 2007). 
Moreover, such an analysis shows that the benefits exceed the risks by over 100 to 1, and far 
more if one factors in the severity of the consequences, including mortality and morbidity, 
that can occur in uncircumcised males and their sexual partners in adulthood.  
MC is, without doubt, a multi-benefit procedure. Yet many analyses of its benefits make the 
mistake of addressing its effect with respect to just one medical condition. For a true 
assessment of its value it is necessary to carry out a summation of all the benefits, quoting 
the total inclusive of spin-offs every time. 
Because of the current focus on efficient and effective MC in regions of the world where HIV 
prevalence is high, in the present chapter we will begin by summarizing the HIV findings. 
In the context of biomedical engineering, we will then examine the devices that have been 
devised for the surgical procedure itself. The intention of these devices has been to help 
reduce risk to delicate penile structures during surgery and also to ensure a favourable 
cosmetic outcome of the circumcision procedure. 
2. Male circumcision for HIV prevention 
In 2007 MC was endorsed by the World Health Organization (WHO) and the Joint United 
Nations Programme on HIV/AIDS (World Health Organisation and UNAIDS, 2007a) as 
being an important, proven strategy for prevention of heterosexually-transmitted HIV in 
high prevalence settings. Such advice was the culmination of 20 years of research that led to 
the findings of three large randomized controlled trials in different parts of sub-Saharan 
Africa (Auvert et al., 2005; Bailey et al., 2007; Gray et al., 2007). After rigorous examination of 
the data, the Cochrane committee concluded that “inclusion of male circumcision into 
current HIV prevention guidelines is warranted” and that “No further trials are required” 
(Siegfried et al., 2009; Siegfried et al., 2010). A recent analysis of data from 18 sub-Saharan 
African countries found the protective effect after adjustment for number of lifetime sexual 
partners and socio-demographic variables was 5-fold (Gebremedhin, 2010). As a result, 
large-scale MC programmes are being rolled out across sub-Saharan Africa in societies 
where traditional circumcision has not in recent times been the norm.   
Therefore, whilst the long-term goal should be one of circumcising in infancy, the 
immediate need in settings where life-threatening HIV prevalence is high is to circumcise 
uninfected heterosexually-active adult and adolescent males. 
Critics of this approach cite the "ABC" policy (Abstinance, Behaviour, Condoms) (Coates et 
al., 2008) as being sufficient. While condoms are 80–90% effective if always used properly 
(Halperin et al., 2004), including during foreplay, the reality is that for a host of reasons such 
as passion over-riding common sense, dislike for condoms, reckless behaviour often fuelled 
by inebriation, and/or not having a condom available, many people either do not use them 
consistently or at all (Donovan & Ross, 2000; Szabo & Short, 2000; Caballero-Hoyos & 
Villasenor-Sierra, 2001; Ferrante et al., 2005; Jadack et al., 2006; Kang et al., 2006; Sanchez et 
al., 2006; Yahya-Malima et al., 2007; Munro et al., 2008; Wawer et al., 2009). This research 
included RCTs in which men were given counselling and free condoms (Wawer et al., 2009). 
A review of 10 studies from Africa found that overall there was no association between 
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condom use and reduced HIV infection, with two studies actually showing a positive 
association between use of a condom and HIV infection (Slaymaker, 2004; Lopman et al., 
2008). Part of the reason, however, is that condom use is likely to be higher when one person 
knows they are HIV-positive and does not want to infect their partner. Circumcision can 
thus be regarded as providing backup protection. It is much like seatbelts and airbags used 
in combination to reduce the road toll (Cooper et al., 2010). Buckling up the seatbelt has to be 
done, whereas the airbag is always there. Imperfect though it is, once circumcised a male 
enjoys a guaranteed degree of protection for life. The widespread acceptance of MC as an 
important HIV prevention measure has led to a new “ABC” now being advocated: 
Antivirals, Barriers and Circumcision. Not instead of the original ABC, but additionally. 
This clearly recognizes that MC is part of a package of prevention measures. 
An as-treated meta-analysis of the initial findings from the three RCTs found that the 
protective effect was 65% (Weiss et al., 2008). This was identical to the summary risk ratio for 
the 15 observational studies that adjusted for potential confounders. Follow-up analyses 
have indicated an increase in the 60% protective effect seen in the Kenyan trial to 65% at 3.5 
years (Bailey et al., 2008)  and 4.5 years (Bailey et al., 2010) In the Ugandan trial by 5 years the 
protective effect had increased to 73% (Kong et al., 2011). Such a level of protection is similar 
to that afforded by influenza vaccines (Fiore et al., 2007; Kelly et al., 2009). Even higher 
protection (80%) was found in the analysis of data from 18 sub-Saharan African countries 
(Gebremedhin, 2010). 
The high protective effect of MC should not detract from the need to adopt the other ABC 
measures as well.  
MC also reduces HIV infection in women by 20–46% (Baeten et al., 2009; Weiss et al., 2009; 
Baeten et al., 2010; Hallett et al., 2010). Economic analyses have estimated enormous savings 
in lives and cost by adoption of widespread MC in high risk settings (Williams et al., 2006) 
and has the potential to abate the epidemic over the next 10–20 years (Gray et al., 2008). Even 
in low prevalence settings such as the USA, infant MC was shown to be cost-saving for HIV 
prevention (Sansom et al., 2010).  
Several different partial remedies can act cumulatively, each contributing not just towards a 
reduction in infection rates but also towards the ultimate public health goal of herd 
immunity. It is here, rather than in the realms of individual healthcare, that the true value of 
MC lies. Not surprisingly, MC is now regarded as a “surgical vaccine” (Morris, 2007; 
Schoen, 2007b; Ben et al., 2009). It provides a behaviour-independent secure foundation 
upon which other forms of protection can build. 
As a prelude to the discussion of MC technique and the various devices for achieving 
foreskin removal, it is important to emphasize the biological evidence that has now 
accumulated that indicates the vulnerability of the inner lining of the foreskin to infection of 
the man by HIV.  
During an erection the foreskin can either retract fully or only partially. Either way, during 
intercourse the thin, mucosal inner surface of the foreskin is exposed to the partner's body 
fluids (Szabo & Short, 2000). The foreskin then traps the infectious inoculum when the penis 
becomes flaccid again (Cameron et al., 1989). The mucosal inner lining is only lightly 
keratinized (Patterson et al., 2002; McCoombe & Short, 2006; Ganor et al., 2010) and is rich in 
Langerhans cells (Patterson et al., 2002). Dendrites from these project to just under the 
surface (McCoombe & Short, 2006). The higher susceptibility of the inner lining to infection 
by live, tagged HIV has been demonstrated in cultured tissue (Patterson et al., 2002). 
Internalization of HIV involves the presence on Langerhans cells of the c-type lectin, 
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Langerin, that can bind HIV and internalize it (Turville et al., 2002). The Langerin is then 
involved in its transport to regional lymph nodes (Turville et al., 2002). In the inner (but not 
the outer) foreskin, tumor necrosis factor- can activate Langerhan’s cells; stimulatory 
cytokines then cause an influx of CD4+ T-cells into the epithelial layer (Fahrbach et al., 2010). 
The higher permeability of the inner foreskin is associated with increased interaction of HIV 
target cells with external factors, such as HIV. HIV can, moreover, infect T-cells 
independently of Langerhans cells (Boggiano & Littman, 2007). HIV’s success in establishing 
a systemic infection might nevertheless depend on its early interaction with Langerhans 
cells (Boggiano & Littman, 2007; Hladik et al., 2007). At low viral levels Langerin is able to 
clear HIV, shunting it to intracellular granules for degradation, but this mechanism becomes 
overwhelmed at higher viral loads (de Witte et al., 2007; Schwartz, 2007). By confocal 
imaging microscopy and mRNA quantification, the demonstration of abundant and 
superficially present potential HIV target cells (CD3+ and CD4+ T-cells, Langerhans cells, 
macrophages and submucosal dendritic cells) has provided anatomical support for the 
protective effect of circumcision (Hirbod et al., 2010). There was no difference between 
positive and negative HSV-2 serostatus.  
In 2010 it was found that HIV infected cells, but not free HIV, form viral synapses with 
apical foreskin keratinocytes, followed by rapid internalization by Langerhans cells, whose 
projections (dendrites) weave up between the keritanocytes in the inner foreskin, the 
infection occurring within 1 hour (Ganor & Bomsel, 2010; Ganor et al., 2010). The 
Langerhans cells then formed conjugates with T-cells thereby transferring the HIV. The 
thick keratin layers in the outer foreskin prevent infection (Ganor & Bomsel, 2010). 
Ulcerative disease and tearing are more common in uncircumcised men, adding to the risk of 
HIV entry (Alanis & Lucidi, 2004). A large 2-year RCT found significantly lower penile coital 
injuries amongst men in the circumcised arm of the trial, adjusted odds ratio being 0.71 for 
soreness, 0.52 for scratches/abrasions/cuts, and 0.62 for bleeding (Mehta et al., 2010). HSV-2 
infection increases HIV risk in men and women by 3-fold (Freeman et al., 2006). Men with a 
higher foreskin surface area appear more likely to be infected with HIV (Kigozi et al., 2009b). 
Inflammation of the epithelium of the foreskin is another factor that can increase infection risk 
and has been noted in 4.2% of men with neither HIV nor HSV-2, 7.8% of men with HSV-2 only, 
19% of men with just HIV, and 32% of men with both (Johnson et al., 2009). For stromal 
inflammation, the figures were 14%, 30%, 33% and 61%. Both epithelial and stromal 
inflammation were more common in men with accumulations of smegma. Even in the absence 
of visible lesions the mucosal tissue can show histological signs of inflammation (Hirbod et al., 
2010). Wetness under the foreskin is an indicator of poor hygiene and is associated with a 40% 
increase in risk of HIV infection (O'Farrell et al., 2006). A wet penis may enhance attachment of 
infectious virions for longer, reduce healing after trauma, or may lead to balanitis under the 
foreskin and consequent micro-ulcerations (O'Farrell et al., 2006). 
In high HIV prevalence settings, MC has been shown to be cost-effective for prevention of 
this virus (Williams et al., 2006; Uthman et al., 2011). In sub-Saharan Africa the cost of MC is 
always lower than the cost of anti-retroviral treatment; by how much depends on the 
method of circumcision used. Prevention is of enhanced importance here, because no 
outright cure currently exists for HIV infection. 
As mentioned earlier, even in settings in which HIV prevalence is low – such as the USA – 
calculations by the Centers for Disease Control and Prevention (CDC) have indicated that 
circumcision of infants would be cost-saving for HIV prevention (Sansom et al., 2010). The CDC 
has been giving favourable consideration, based on the wide-ranging benefits, to encouraging 
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infant MC in the USA (Smith et al., 2010). Earlier analyses, based on just some of the benefits, 
were favourable (Schoen et al., 2006). These did not consider the benefits to women such as 
reduction in cervical cancer and various STIs besides oncogenic HPV (Morris et al., 2006). 
The ongoing penetration of HIV into the heterosexual community and rise in the number 
and proportion of new diagnoses from heterosexually-acquired infection in previously low 
HIV prevalence settings has led to calls for MC to be encouraged strongly in infancy 
(Cooper et al., 2010). 
3. Rates of circumcision 
Worldwide 30–32% of males are circumcised (World Health Organization, 2008b). Most are a 
consequence of Muslim tradition that mandates MC. Religion dictates MC at day 8 for Jewish 
infants. In much of sub-Saharan Africa and other parts of the world such as indigenous 
peoples of Australia and the Pacific islands, MC is performed as part of coming of age 
ceremonies for boys. In the 1800s MC became popular in Britain and countries with an Anglo-
Celtic heritage such as the USA and Australia. While a decline took place in the UK starting in 
the 1930s and in Australia and New Zealand in the 1970s, rates in the USA have remained high 
amongst Anglo-Celtic whites and Afro-American blacks (Xu et al., 2007). Hospital discharge 
data that suggest a decline do not take into account earlier discharge from maternity wards 
shifting the procedure from hospitals (where circumcisions are recorded in official statistics) to 
doctor's offices (where they are not), and the fact that not all hospitals record infant MC after 
delivery. The campaigning by MC opponents that led to withdrawal of Medicaid funding for 
MC in 17 states has had an adverse effect on the ability of the poor to access MC services for 
their children (Leibowitz et al., 2009; Morris et al., 2009). In a 2008 report, hospital discharge 
data in Maryland found 75.3% of 96,457 male infants were circumcised after birth and survey 
data from 4,273 mothers showed a rate of 82.3% (Cheng et al., 2008). Rate was higher in white 
and Afro-American blacks and lower amongst Hispanic and Asian infants. The continued 
influx of migrants, mostly Hispanic, in whom MC is culturally foreign, has been a major factor 
in the declining prevalence of MC in the US population as a whole. Subsequent generations 
are, however, more likely to adopt local US customs by having their baby boys circumcised. In 
Australia a reversal of the downward trend has become evident, no doubt fuelled by 
widespread news media publicity of the many benefits, especially in HIV prevention. 
4. Circumcision style: Terminology 
Excision of the foreskin can adopt various styles. These can be divided into what is referred 
to commonly as either a “high'” or a “low” style (Fig. 1). 
There is no published evidence as to whether one style or the other offers greater protection 
from HIV. The RCTs of MC for HIV prevention used either the forceps-guided method (which 
is “moderately high and loose”: http://www.circlist.com/instrstechs/forcepsguide.html) 
(Auvert et al., 2005; Bailey et al., 2007) or the sleeve technique (which is “high” and either 
“tight” or “loose”: http://www.circlist.com/ instrstechs/doublecirc.html) (Gray et al., 2007). 
Proponents of the “low” style argue that the antigen receptor cells responsible for admitting 
HIV to the uncircumcised male are concentrated in the frenulum and inner foreskin, implying 
that this tissue should be removed completely in order to obtain maximum benefit from the 
circumcision. Opponents consider that post-circumcision changes in residual mucosal tissue 








Fig. 1. Depiction of flaccid penis before and after circumcision showing what gets removed 
for extremes of style; in each case the tissue to be removed is shown in orange. (A) before 
and (B) after for the “low and loose” style: Almost all the inner foreskin has been removed 
along with an equal amount of outer foreskin. No tension has been placed in the shaft skin, 
with the result that the flaccid penis droops and the sulcus is not held fully open. Thus, 
despite circumcision, it remains possible for smegma to accumulate. (C) before and (D) after 
for the “low and tight” style: The maximum possible amount of inner foreskin has been 
removed along with the whole of the outer foreskin plus a considerable portion of shaft skin. 
This has placed the residual shaft skin under tension, with the result that the flaccid penis 
appears to be short and semi-erect. The sulcus is held fully open; therefore it is not possible 
for smegma to accumulate. (E) before and (F) after for the “high and loose” style: Much of 
the of inner foreskin has been retained, folded back on itself to face outwards and assume 
the role of shaft skin. The outer foreskin has been removed along with some shaft skin, but 
not enough to place the residue under tension. Thus the flaccid penis still droops as it did 
before circumcision. The sulcus is not held fully open; therefore it is still possible for 
smegma to accumulate. (G) before and (H) after for the “high and tight” style: Much of the 
inner foreskin has been retained, folded back on itself to face outwards and assume the role 
of shaft skin. The outer foreskin has been removed, as has a considerable amount of shaft 
skin. This has placed the residual shaft skin under tension, with the result that the flaccid 
penis appears to be short and semi-erect. The sulcus is held fully open; therefore it is not 
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view is that, unless or until proof positive emerges to the effect that a “high” style confers as 
great a degree of prophylaxis as a “low” style, the Precautionary Principle should be applied 
and circumcisions should be done in the “low” style. 
Traditional circumcisions done using "tug-&-chop" methods (Fig. 2) already provide us with 
ample examples of residual inner foreskin. There appears to be scope for a population study 




Fig. 2. The “tug-and-chop” method of circumcision. 
Another somewhat contentious style issue is the matter of tightness. Often, tightness is 
considered to be nothing more than a cosmetic matter. However, theoretical models of STI 
transmission tend to suggest that benefit is gained from the sulcus being dry. This implies 
that circumcisions should be sufficiently tight to hold the sulcus open, such that no moisture 
will accumulate there. 
The third style issue to be resolved relates to removal or retention of the frenulum. As well 
as having high concentrations of antigen receptor cells targeted by HIV, the highly vascular 
frenulum is particularly susceptible to tearing or other damage during intercourse, as well 
as being a frequent site of lesions produced by other STIs (Szabo & Short, 2000). Persistent 
debate relates to resulting changes in sexual sensitivity; anecdotal evidence from those who 
have had their frenulum surgically removed suggest that no loss of sensitivity occurs. It is 
also worthy of note that the frenulum can be lost as a result of tearing; such loss does not 
appear to give rise to complaint about effects long-term. 
In the light of all of the above, there appears to be a good cause not just to circumcise but to 
circumcise in a particular way.  It seems appropriate for the surgery to specifically target 
certain classes of cells for removal, at the same time achieving a result that holds the sulcus 
open so that it remains dry and clean, unable to harbour a viral payload either in smegma or 
in residues of erogenously triggered body fluids. 
5. Methods of circumcision 
We will now present information on current approaches to circumcision, mostly stemming 
from experience in developed nation settings, the USA in particular. We will start with 
infants and then move on to adults and older boys. We will end with speculation about 
what is needed for low-resource settings in terms of devising novel devices. 
There is no standard circumcision procedure and the issue of standards has been a rallying 
call for years. At the Western Section American Urological meeting in 2007 Dr Sam Kunin, 
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who practices in Los Angeles, compared and contrasted clamps and discussed what he 
considered should be the minimal standards for circumcision (Kunin, 2007a). 
The postnatal period provides an ideal window of opportunity for circumcision (Schoen, 
2007a). The newborn, having recently experienced the considerable trauma of birth, has 
elevated levels of normal stress-resistance hormones. Neonates heal quickly, are resilient, 
and use of local anaesthesia means little or no pain. Since the inner and outer foreskin layers 
readily adhere to each other afterwards, sutures are rarely needed in this age group.  
 
 
Fig. 3. Photo of a baby boy having a circumcision. 
There is no evidence of any long-term psychological harm arising from circumcision. The 
risk of damage to the penis is extremely rare and avoidable by using a competent, 
experienced doctor. Unfortunately, because it is such a simple, low-risk procedure, it had 
once been the practice to assign this job to junior medical staff, with occasional devastating 
results. Anecdotes of such rare events from the past should be viewed in perspective.  
Parents or patients nevertheless need to have some re-assurance about the competence of 
the operator. Also the teaching of circumcision to medical students and practitioners needs 
to be given greater attention because it is performed so commonly and needs to be done 
well. Models to teach interns and others have, moreover, been produced (Erikson, 1999; 
Cohen, 2002). 
6. Traditional circumcision of infants 
Surgical methods often use a procedure that protects the penis during excision of the 
foreskin. 
Safe implementation of the Jewish tradition of circumcision on the eighth day of life led to 
the development of what is termed the "Traditional Jewish Shield". At one time made from 
silver (a material chosen for its natural aseptic qualities), the identical method is now to be 
found in conjunction with single-use disposable equipment. The objective of the device is to 
prevent accidental injury to the glans. 
The traditional Jewish equipment typifies the "Tug-&-Chop" method. Similar shielding can 
equally be achieved with forceps or a haemostat, whereupon it becomes known as the 
forceps-guided technique. Cutting can be done with scissors, a scalpel or an electrocautery 
device. In all instances the mucosal skin that is stretched between the sulcus and the distal 
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face of the shield remains intact. Given the current state of knowledge, such a style of 
circumcision must be regarded as sub-optimal. 
Wholly freehand circumcisions did occur, but at theoretically greater risk of injury to the 
glans. 
None of the traditional devices automatically result in removal of the frenulum. If that is 
required, it must be done as a separate procedure. 
7. Medical circumcision of infants and very young boys 
In the 1930s in the United States, the search for a means of bloodless circumcision of infants 
began. Yellen set out the principles involved (Yellen, 1935), but it fell to others (Goldstein, 
1939; Ross, 1939; Bronstein, 1955; Kariher & Smith, 1955) to produce workable devices to 
implement the concept. Numerous patent applications for circumcision instruments were 
filed during this period, especially in the United States as can be seen by referring to the US 
Patent and Trademark Office database (USPTO), but few of the inventions passed into mass 
production and routine use. Meantime, in Europe, a similar but apparently unpatented 
device known as the Winkelmann Clamp was gaining favour (untraced in the European 
Patent Office database). 
Such devices can be divided into two categories: Those that rely on ischaemic necrosis and 
those that do not. Ischaemic necrosis involves the deliberate killing-off of tissue by 
strangulation of its blood supply for a period of days, as in the Ross Ring and the Plastibell® 
(the trade name given to Kariher and Smith's device). The other devices first crush the blood 
vessels, typically for a period of some minutes, and then provide protection for the glans 
when the foreskin is severed. Conventional wound healing follows. In infants, the crushing 
action is sufficient to seal the wound such that sutures are not normally needed. 
In consequence of the design fundamentals of the Gomco (GOldstein Medical COmpany) 
clamp (the trade name given to Goldstein's device) and the Winkelmann Clamp, these two 
clamps have the potential to remove almost all inner foreskin. The inner, "bell" component 
reaches beneath the prepuce in a way that places the cut near to the coronal rim of the glans. 
In consequence, as regards HIV prophylaxis, the resulting style of a circumcision done with 
these clamps is preferable to any "Tug-&-Chop" method. 
In the USA the most commonly used devices are the Gomco clamp (67%), the Mogen clamp 
(10%) and the Plastibell (19%) (Stang & Snellman, 1998). Pictures of these appear later and 
can also be found in references: (Langer & Coplen, 1998; Alanis & Lucidi, 2004). The latter 
article in particular discusses the procedure, as well as contraindications. A technique that 
uses the Plastibell as a template for paediatric circumcision has been developed (Peterson et 
al., 2001). Rather than waiting for the bell to slough off days later, sutures are made at the 
time and the bell is removed. A similar “adult circumcision template” was later created for 
use in men, with good results (Decastro et al., 2010).  
The various devices serve to protect the penis when excising the prepuce. The type of clamp 
used affects the time taken for the procedure, being on average 81 seconds for the Mogen 
clamp and 209 seconds for the Gomco clamp (Kurtis et al., 1999). In a head-to-head trial of 
length of procedure the Mogen took 12 minutes, compared with 20 minutes for the Plastibell 
(Taeusch et al., 2002). The latter time is far greater than others generally achieve (see 8.2.4 
below). Although simpler to use and more pain-free than the other two (Kurtis et al., 1999; 
Kaufman et al., 2002; Taeusch et al., 2002), the Mogen clamp removes less foreskin. The 
Gomco is the oldest and is the most refined instrument (Wan, 2002). Its use is widespread, a 
study in Togo confirming its superiority to grips-only circumcision (Gnassingbé et al., 2010). 
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Since some of these more elaborate methods can take up to 30 minutes to perform they 
therefore expose the baby to a greater period of discomfort. In contrast, a circumcision can 
be completed in 15–30 seconds by a competent practitioner using methods that are part of 
traditional cultures.  
Interestingly, strict sterile conditions were reported not to be necessary to prevent infection 
in ritual neonatal circumcision in Israel (Naimer & Trattner, 2000).  
Rather than tightly strapping the baby down, swaddling and a pacifier has been suggested 
(Herschel et al., 1998; Howard et al., 1998; Howard et al., 1999). A special padded, 
“physiological” restraint chair has moreover been devised and shown to reduce distress 
scores by more than 50% (Stang et al., 1997). Exposure to a familiar odour (the mother’s milk 
or vanilla) reduces distress after common painful procedures in newborns (Goubet et al., 
2003; Rattaz et al., 2005; Goubet et al., 2007). 
Dr Tom Wiswell and other experts strongly advocate the neonatal period as being the best 
time to perform circumcision, pointing out that the child will not need sutures (owing to the 
thinness of the foreskin (Schoen, 2005)) nor general anaesthesia, or additional hospitalization 
(Wiswell & Geschke, 1989; Wiswell & Hachey, 1993; Wiswell, 1995; Wiswell, 1997; Wiswell, 
2000). Wiswell pointed out (personal email communication in Apr 2009) that “starting in the 
1970s there was a movement away from delivery room circumcisions at minutes of life until 
several hours to several days of life. This was mainly because of the recognition of the 
transition period to extrauterine life that babies go through. ‘Stresses’ can have an adverse 
effect on this process, particularly on the heart and lungs. In an otherwise healthy infant, 
though, there is no need to delay until 2 weeks of age.” 
All circumcisions should involve adequate anaesthesia, using either EMLA cream,  
dorsal penile nerve block, penile ring block, or a combination of these prior to the operation 
(http://www.circinfo.net/anesthesia.html). Without an anaesthetic the child experiences 
pain, during the procedure and for a maximum of 12–24 hours afterwards. That the  
baby could remember for a short time was suggested by a greater responsiveness to 
subsequent injection for routine immunization (Taddio et al., 1997). The child does not, 
however, have any long-term memory of having had a circumcision performed and there 
are no other long-term adverse effects (Fergusson et al., 2008). Local anaesthesia is therefore 
advocated.  
Whatever the method, post-operative care, as advised by the doctor, must be undertaken, 
usually by the parents. Cosmetic results have met with unanimous parental acceptance 
(Duncan et al., 2004).  
Healing is rapid in infancy (Schoen, 2005), complication rate is very low (0.2%–0.6%) 
(Wiswell & Geschke, 1989; Cilento et al., 1999; Christakis et al., 2000; Ben Chaim et al., 2005), 
and cost is much lower than when performed later in life (Schoen et al., 2006). 
For males with haemophilia, special pre-operative treatment is required (Balkan et al., 2010; 
Yilmaz et al., 2010). A satisfactory outcome can be achieved with a specialized cost-effective 
device (Karaman et al., 2004; Sewefy, 2004). Just as for healthy individuals (see below), 
cyanoacrylate tissue adhesives (Glubran and Glubran 2) have been found to be effective for 
circumcision of haemophilia patients (Haghpanah et al., 2011). 
8. Circumcision of adults and boys post-infancy 
8.1 Freehand methods 
Circumcision is more traumatic, disruptive and expensive for men and older boys than it is 
for infants (Schoen, 2007a). For those aged 4 months to 15 years some authorities advocate a 
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general anaesthetic. Others strongly disagree, saying that since a general anaesthetic carries 
a small risk, a local anaesthetic, often with a mild sedative, is what should be used for all 
children (Schoen, 2007a).  
Unlike infant circumcisions, sutures/stitches or wound staples are usually needed for men 
and older children, although use of synthetic tissue adhesives such as 2-octyl-cyanoacrylate 
(Dermabond) (Cheng & Saing, 1997; Subramaniam & Jacobsen, 2004; Ozkan et al., 2005; 
Elmore et al., 2007; Elemen et al., 2010; Lane et al., 2010; D'Arcy & Jaffry, 2011) have proven to 
be effective alternatives. These are safe, easy to use, reduce operating time, lower 
postoperative pain and give a better cosmetic appearance (Ozkan et al., 2005; Elmore et al., 
2007). 
Excellent cosmetic results were reported for all of 346 patients aged 14 to 38 months using 
electro-surgery, which presents a bloodless operative field (Peters & Kass, 1997). Metal of 
any kind (such as the Gomco clamp that is used commonly in infant MC) has to of course be 
avoided in this procedure.  
Laser surgery is gaining popularity, but requires both specialized equipment and training. 
The method has its own associated shields (Chekmarev, 1989; Zhenyuan, 1989; Gao & Ni, 
1999). 
Gentle tissue dissection with simultaneous haemostasis has been achieved using an 
ultrasound dissection scalpel for circumcision (Fette et al., 2000).  
A randomized trial found that a bipolar diathermy scissors circumcision technique led to 
less blood loss (0.2 versus 2.1 ml), shorter operating time (11 versus 19 min) and lower early 
and late postoperative morbidity as compared with a standard freehand scalpel procedure 
(Méndez-Gallart et al., 2009). Bipolar scissors also appear to offer a method of bloodless 
removal of the frenulum prior to application of any one of a number of circumcision clamps 
for the remainder of the procedure. 
Unless combined with other surgery, circumcision later obviously requires a separate 
(occasionally overnight) visit to hospital. Healing is slower than in newborns and the rate of 
complications is greater, but still low: 1–4% (Auvert et al., 2005; Cathcart et al., 2006; Bailey 
et al., 2007; Gray et al., 2007; Krieger et al., 2007). Most common is postoperative bleeding 
(0.4–0.8%), infection (0.2–0.4%), wound disruptions (0.3%), problems with appearance 
(0.6%), damage to the penis (0.3%), insufficient skin removed (0.3%), delayed wound 
healing (0.1%), delayed healing (0.2%), swelling at the incision site or haematoma (0.1–0.6%) 
or need to return to the theatre (0.5%). An average of 3.8% adverse events has been seen for 
the first 1–100 circumcisions a clinician does (Krieger et al., 2007). For the next 100 this 
decreases to 2.1% and by the time they have done 200–400 it drops to less than 1%. Beyond 
400 it is 0.7%. The incidence of penile adhesions after a circumcision decreases with age, but 
at any age they often resolve spontaneously (Ponsky et al., 2000). Pain sometimes can last for 
days afterwards and those older than 1 to 2 years may remember. 
Cost is also much greater than for neonatal circumcision. Cost can be reduced by having the 
surgery performed on an outpatient basis.  
A local anaesthetic is all that is needed for MC, so reducing anaesthetists’ charges which can 
be quite high for a general anaesthetic. The WHO has produced a manual for circumcision 
of men under local anaesthesia (World Health Organisation, 2006). Various methods can be 
used for local anaesthesia, including dorsal penile nerve block and ring block. Recently, a 
no-needle jet of 0.1 ml 2% lidocaine solution sprayed at high pressure directly on to the 
penile skin circumferentially around the proximal third of the penis has proven to be quick 
and effective, and has obvious appeal (Peng et al., 2010a). 
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Conventional surgery under general anaesthetic normally uses the sleeve-resection 
technique, described in a series of diagrams with technical details by Elder (2007). This 
method takes longer and for this reason many surgeons will insist on using a general 
anaesthetic. By its nature sleeve resection removes mainly shaft skin, not foreskin, so having 
potential implications for HIV infection. An alternative is the Dissection Method. These two 
methods are often confused. Illustrated by Mousa (Mousa, 2007), the Dissection Method 
separates inner and outer foreskin in a manner similar to a very loose "tug and chop" 
circumcision, but then proceeds to excise most of the inner and all of the outer foreskin 
along with some shaft skin. The amount of shaft skin removed depends on the tightness 
required; inner foreskin is left only as necessary to provide an anchorage for sutures 
reconnecting the shaft skin to the sulcus. 
Interestingly, genital surgery in women often involves a course of topical estrogen in 
advance in order to increase thickening, cornification and keratinization of the vaginal 
epithelium (Short, 2006). This helps surgical outcome and has led to the suggestion that 
similar pre-treatment be carried out prior to circumcision in men. 
Pain from conventional surgery can last for up to a week or longer afterwards, during which 
time absence from work may be required. Some men, however, report no pain, just minor 
discomfort from the stitches. A large RCT found that at the 3-day post-circumcision follow-up, 
48% reported no pain, 52% very mild pain, and none moderate or severe pain (Bailey et al., 2007). 
By 8 days, 89% had no pain and 11% mild pain. Vasectomy in men circumcised previously as 
adults (and who can thus attest to the difference) is said to be much more painful.    
8.2 Instruments developed over earlier years 
The following devices were in common use for male circumcision prior to the start of the 
HIV epidemic. The patent information quoted relates to the country of residence of the 
inventor(s). In many instances other patents exist, especially in the USA, the European 
Union and, since its formation in 1967, the records of the World Intellectual Property 
Organisation (WIPO). 
8.2.1 Traditional Jewish shield 
Inventor:  Unknown 
Primary patent:  None: historic  
Patent priority date: Not applicable 
Patient age range: Full-term neonate to adult 
Category:  Tug-&-Chop shield 
 
 
Fig. 4. The traditional Jewish shield. 
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Procedure: The foreskin is pulled forward and the shield slipped over it. The excess prepuce 
is then excised by running a scalpel or similar knife across the distal face of the device. 
8.2.2 Gomco Clamp 
Inventor:  Goldstein, A.A. 
Primary patent:  United States Design Patent USD119180 (no Utility Patent has 
   been traced)  
Patent priority date:  16 Mar 1939 
Patient age range: Full-term neonate to adult 
Category:  Bell clamp / scalpel guide 
 
 
Fig. 5. The Gomco Clamp showing components, in a range of sizes, that are assembled 
during the procedure described in the text. 
Procedure: First of all, a dorsal slit is made in the foreskin and the foreskin is separated from the 
glans. The bell of the Gomco clamp is then placed over the glans, and the foreskin is pulled 
over the bell. The base of the Gomco clamp is placed over the bell, and the Gomco clamp's arm 
is fitted. After the surgeon confirms correct fitting and placement (and the amount of foreskin 
to be excised), the nut on the Gomco clamp is tightened, causing the clamping of nerves and 
blood flow to the foreskin. The Gomco clamp is left in place for about 5 minutes to allow 
clotting of blood to occur, then the foreskin is dissected off using a scalpel. The Gomco's base 
and bell are then removed, and the penis is bandaged. It is a fairly bloodless circumcision 
technique. The circumcision is relatively quick compared to the Plastibell. It was the most 
popular method for circumcisions between 1950 and 1980 and is still common today, 
especially in the USA. A training video of a neonatal Gomco circumcision using dorsal penile 
nerve block and a sucrose pacifier, conducted by Dr Richard Green, Stanford University 
School of Medicine, is available at http://newborns.stanford.edu/Gomco.html 
Dr Sam Kunin, an experienced urological surgeon in Los Angeles, has developed a clever, 
and very effective, method in which local anaesthetic is injected into the distal foreskin 
(Kunin, 2007b). Doing so separates the inner and outer foreskin therefore allowing the inner 
layer to be pulled against the bell of the Gomco clamp, and results in a maximum amount of 
inner layer being removed (http://www.samkuninmd.com). He points out that the inner 
lining is the area most prone to adhesions, irritations, yeast and bacterial infections, 
particularly in diabetics. 
Gomco clamps exist in sizes from neonatal to adult. Suturing is required post-infancy. 
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8.2.3 Winkelmann Clamp 
Inventor:  Provisionally attributed to the German urological 
    surgeon Karl Winkelmann (1863–1925). 
Primary patent:  None traced 
Patent priority date: None traced 
Patient age range: Infant to mid-puberty, according to manufacturer. 
Category:  Bell clamp / scalpel guide 
 
 
Fig. 6. The Winkelmann Clamp. 
Procedure: Nominally the same as the Gomco clamp described above. Despite its ready 
availability, the Winkelmann Clamp appears not to have been trialled in connection with the 
search for devices suitable for campaigns of mass circumcision. 
8.2.4 Plastibell 
Inventors:  Kariher, D.H. and Smith, T.W. 
Primary patent:  US3056407 
Patent priority date: 18 May 1955 
Patient age range: Full-term neonate to onset of puberty 
Category:  Ischaemic necrosis device using string ligature 
Procedure: The Plastibell is a clear plastic ring with handle and has a deep groove running 
circumferentially. The adhesions between glans and foreskin are divided with a 
haemostat (artery forceps) or similar probe. Then the foreskin is cut longitudinally 
starting at the distal end dorsally to allow it to be retracted so that the glans (the head of 
penis) is exposed (Elder, 2007). The appropriately sized device is chosen and applied to 
the exposed glans. The ring is then covered over by the foreskin. A ligature is tied firmly 
around the foreskin, crushing the skin against the groove in the Plastibell. Then the excess 
skin protruding beyond the ring is trimmed off, something that is possible using surgical 
scissors rather than a scalpel. Finally, the handle is broken off. The entire procedure takes 
5 to 10 minutes, depending on the experience and skill of the operator. The compression 
against the underlying plastic shield causes the foreskin tissue to necrotize. The ring falls 
off in 3 to 7 days leaving a circumferential wound that will heal over the following week. 
Typically, the glans will appear red or yellow until it has cornified (Gee & Ansell, 1976; 
Holman et al., 1995).  
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Fig. 7. The Plastibell device is a clear plastic ring with handle and has a deep groove running 
circumferentially. Upper diagram: How it is used for an infant circumcision (diagram 
modified from Elder (2007)). Lower image: Dr Terry Russell, Brisbane, Australia, displaying 
the range of sizes available. 
The Plastibell continues to be available in sizes applicable from newborn to early puberty. 
The metallic precursor, the Ross Ring (Ross, 1939), also came in adult sizes, but adult 
Plastibell circumcision appears to be unknown. The metallic ring is long discontinued, 
rendered obsolete by its disposable plastic equivalent. Cosmetic results have met with 
unanimous parental acceptance (Duncan et al., 2004). 
Dr Terry Russell in Brisbane, Australia, developed in 1993 a simple, pain-free method 
involving 2 hours EMLA cream with the penis wrapped in cling wrap (done by the parents 
prior to arrival at the clinic), followed by a modified Plastibell circumcision (Russell & 
Chaseling, 1996). The technique is described in detail on his website 
(http://www.circumcision.com.au). Dr Russell has used it in 30,000 circumcisions on boys 
of all ages from neonate to puberty, including 400 older boys every year. More recently he 
has obtained excellent results with another topically applied anaesthetic cream, LMX4 (4% 
lidocaine) that is faster acting, more effective and has fewer side effects (C.T. Russell, 
personal communication). Because complete local anaesthesia is achieved by EMLA or 
LMX4 cream, Dr Russell reports that no pain is experienced for 5 hours after the Plastibell is 
applied, so claims the circumcision is completely pain free at all stages. The only major 
complication in 30,000 circumcisions was one boy who developed mild 
www.intechopen.com
 
Biomedical Engineering – From Theory to Applications 
 
330 
methemoglobinaemia (from the EMLA cream) that, after immediate hospital admission, 
resolved spontaneously overnight, with no medical intervention required.  
Prof Roger Short orchestrated the production of a video that teaches the Russell method. Dr 
Russell featured in this "no scalpel circumcision" video. Also featured was one of Prof 
Short’s students from Botswana, who took it there for teaching purposes. Another, filmed in 
Vanuatu of a traditional circumcision using a sharpened bamboo, was produced for use in 
Papua New Guinea (PNG) where, unlike most Pacific Islands, circumcision is uncommon. 
These were aimed primarily to reduce HIV/AIDS in Botswana and PNG. 
Since the simple plastic Plastibell device is now off patent it can be produced at very low 
cost, but parallel production cannot use the name Plastibell, which remains to this day a 
Registered Trade Mark. Nevertheless, the device has the potential to help reduce HIV in 
poor countries (Short, 2004). 
Dr. Sam Kunin points out, however, that "the [Plasti]bell techniques leave too much inner 
skin. Besides the inherent problems of this method with later adhesions and buried penis, 
allows for possible migration of the bell down the shaft, with ensuing potential damage to 
the penile skin" (personal communication). A Nigerian study also noted that incorrect 
technique can lead to proximal migration of the Plastibell in neonatal boys (Bode et al., 2009). 
Correct training in this method is thus essential. An Iranian study involving 7,510 term 
neonates found that Plastibell circumcision incorporating thermal cautery of the frenulum 
reduces bleeding (0.4% versus 0.05%), but led to greater urinary retention (0.03% versus 
0.9%) (Kazem et al., 2009). Modifications to the standard procedure by authors in the UK 
have improved outcomes, particularly the risk of bleeding (Mahomed et al., 2009). 
A study in Pakistan found that for babies under 3 months of age, the time taken for the 
Plastibell to fall off was 8.7 days (Samad et al., 2009). This increased gradually to 16.8 days 
for children over 5 years. 
8.2.5 Mogen Clamp 
Inventor:  Bronstein, H. 
Primary patent:  US2747576 
Patent priority date: 3 Feb 1955 
Patient age range: Full-term neonate to adult 
Category:  Tug-&-Chop shield with inbuilt crushing action 
 
 
Fig. 8. The Mogen Clamp. 
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Procedure: Firstly, adhesions between glans and foreskin are divided and a haemostat is 
placed along the dorsal midline with its tip about 3 mm short of the corona before being 
locked into place. The Mogen clamp is opened fully. A key step in Mogen circumcision is 
the safe placement of the clamp. To push the glans out of the way, the surgeon's thumb and 
index finger pinch the foreskin below the dorsal haemostat. The Mogen clamp is then slid 
across the foreskin from dorsal to ventral following along the same angle as the corona. The 
hollow side of the clamp faces the glans. Before locking the clamp shut, the glans is 
manipulated to be sure it is free of the clamp's jaw. If it is, the clamp is locked. Once locked 
the foreskin is excised flush with the flat surface of the clamp with a 10 inch blade scalpel. 
The clamp is left on for a few moments to ensure haemostasis. It is then unlocked and 
removed. The glans is liberated by thumb-traction at the 3 and 4 o'clock positions that pull 
the crush line apart. 
This device can be and has been used across the whole age range. However, recent safety 
issues involving the glans being drawn into the clamp are reported to have brought about 
the bankruptcy of the original manufacturer (Tagami, 2010). 
9. Objectives and constraints relating to a campaign of mass circumcision 
With the possible exception of the Plastibell, the traditional devices appear not to be well 
suited to field use by personnel not fully trained as medical professionals. This has led to the 
development of a number of new designs. Before moving on to consider each in detail, we 
first address the issue of the design objectives. 
Over 30% of the world’s male population enters adulthood already circumcised, their 
foreskins having been removed in infancy, childhood or around puberty, either as a 
prophylactic measure for prevention of disease, for hygiene reasons, family tradition, 
cultural reasons, religious requirements, or treatment of foreskin-related medical conditions 
(World Health Organisation, 2007b). That still leaves hundreds of millions of uncircumcised 
males who are (or later in life will become) sexually active, but lack the baseline protection 
provided by MC against a wide range of STIs and other adverse medical conditions. 
Valiant MC scale-up efforts are in progress in sub-Saharan Africa. It is, however, unrealistic 
to expect existing surgical resources to be diverted to the task of circumcising these millions 
of men worldwide. Such expertise is already fully committed elsewhere. What is required is 
an ad hoc contingent of circumcisers, a cohort of people with sufficient training to carry out 
circumcisions safely, effectively, with a good cosmetic outcome and minimum disturbance 
to lifestyle. Given the vast numbers involved, recruitment from outside the pre-existing 
medical profession is inevitable. Such a need has, moreover, been recognized by those "on 
the ground" in sub-Saharan Africa (Sahasrabuddhe & Vermund, 2007; Sharlip, 2008; Wamai 
et al., 2008; World Health Organization, 2008b). 
Herein lies the justification for introducing newer methods of circumcision reliant on 
advances in biomedical engineering. What is needed is a device and method that de-skills 
the surgical process to the point where it can be safely and effectively undertaken by people 
whose prior educational achievement would not otherwise have admitted them to the 
medical profession. Then, and only then, can a campaign of mass circumcision take place 
without major poaching of skilled personnel from other healthcare programmes. 
Prudent planning nevertheless envisages a fully qualified person to be nearby, acting as 
supervisor and capable of completing by conventional surgery any circumcision that goes 
wrong when attempted by ordinary members of the task force using de-skilled 
www.intechopen.com
 
Biomedical Engineering – From Theory to Applications 
 
332 
methodology. Dispensing totally with such supervision and backup would, in the authors' 
opinions, be too risky.  
No matter what method is used, adequate training in technique is crucial. To this end a low-
cost penile model has been developed as a teaching aid for use in low-resource settings 
(Kigozi et al., 2011). 
As with previous global public health campaigns such as the one that successfully 
achieved the eradication of smallpox, it is imperative to bring MC services to the people 
rather than expect the people to visit distant facilities. Take the example of the peasant 
farmer. He cannot leave his livestock and his family unattended for days on end whilst he 
travels, probably on foot, to a clinic many miles away. Hence our second requirement for 
the ideal new MC device: It must be suitable for use in conditions of limited asepsis. A 
clean consulting room in a village health clinic would be a luxury, as would a mobile 
facility built into a shipping container and driven around by truck. Think more in terms of 
a clean cloth draped over a table in a bamboo or mud hut, with village elders in 
attendance waving their ceremonial fly whisks and the circumciser arriving on foot with 
all necessary equipment in a small rucksack. No roads, no electricity, no running water. 
The 2nd author, Chris Eley, saw exactly this at a religiously-motivated circumcision in 
Seram, Indonesia, in 1987 (Operation Raleigh expedition 11E, led by the late Major Wandy 
Swales TD). On that occasion the surgery was done freehand by a well-qualified and 
highly proficient Egyptian doctor, using injected local anaesthesia, forceps, surgical 
scissors and sutures. 
One obvious consequence of such remoteness is that facilities for re-sterilizing equipment 
are non-existent. Therefore the ideal device should be single-use. That applies not only to 
the clamp itself, but also to all ancillary equipment such as any tool needed to close it, plus 
syringes, forceps and so on. Think here of a whole single-use kit packaged as one, not just a 
clamping device on its own. 
Against this outline of medical objectives, social and logistical background, we can begin to 
construct a checklist of the design parameters to be met by candidate devices. 
Already mentioned: 
 Suitable for use by persons without recognised medical qualifications, with limited 
supervision. 
 Suitable for field use; no requirement for an aseptic environment. 
 Single use / disposable. 
To this list must be added: 
 Cost: Rather obviously this needs to be minimized, but the raw cost of the device is only 
a small part of the total financial commitment. Staffing, provisioning and transport in 
remote areas can dwarf the cost of the circumcision device that the team intends to fit. 
The design of the device nevertheless remains crucial. For example, does it need a 
trained attendant to remove it? If so, staffing costs may straight away have escalated in 
comparison with a rival device not routinely requiring such follow-up. 
 Simplicity: The ideal device should be easy to comprehend. Not only does that simplify 
training, it also simplifies the obtaining of each prospective patient's informed consent. 
Simplicity also reduces the possibility of user error. This implies minimizing the 
number of components, avoiding all possibility of mis-assembly (such as getting 
something the wrong way round) and misuse (such as making a scalpel cut on the 
wrong side of a clamping ring). Enter what we politely refer to here as "The Law of the 
Inevitable Cussidness of Inanimate Objects", better known as Sod's (or Murphy’s) Law 
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(http://en.wikipedia.org/wiki/Murphy's_law). If something possibly can go wrong, it 
will. Botched circumcisions cause immense psychological distress. The duty of care 
owed is of the highest order. One good measure of simplicity is the number of 
components in a device, the lower that number the better. 
 Size range: Where the intent is to produce a single design for the whole male population, 
the smallest device should fit a full-term neonate and the largest should fit the most 
well-endowed male. But what about those in-between? There is a balance to be struck 
here between, on the one hand, having a device that is precisely sized so that it is 
correct for each patient and, on the other hand, needing to carry a vast stock of different 
sizes. A certain latitude in sizing is needed, such that an acceptable circumcision results 
even if the device is a few millimetres off the ideal. This is not merely a matter of 
stockholding; critical sizing invites increased error due to the use of mis-selected 
devices and it also increases waste arising when an incorrect size is selected and 
removed from its sterile packaging but discarded before use. 
 Sterility: Delivery to remote locations requires robust packaging, but that is only half the 
story. Not all sterilization processes can be applied to all materials. There are known 
pitfalls with many plastics. Cobalt-60 exposure (gamma irradiation) is a very effective 
way of sterilizing, but is totally unsuited to a number of plastics; many discolour and 
become brittle when irradiated. Full consideration of this materials science issue is 
beyond the scope of the present chapter; just note and beware! The present alternative 
is the environmentally questionable Ethylene Oxide method. In time, it may become 
possible to use ultra-high voltage electrostatic fields on an industrial scale, but that is 
still in the future (Wang et al., 1992; Meijer, 2008). 
 Suitable materials: Devices that are intended to remain in contact with body tissue for an 
extended period must be hypoallergenic. Factors such as contact time and plasticizer 
residues must be scrutinized. The device supply chain should be secure against pirate 
copies and adulteration of the original specification. 
 Disposability: Waste disposal must be managed, not just in respect of the usual medical 
sharps, but also in respect of sloughed-off clamps and associated necrotic tissue. In 
some societies the payment of a bounty for the return of the spent device might be 
appropriate as a way of bringing about proper disposal. 
 No fraudulent re-use: Single-use devices should be exactly that. A key question might be 
"Does the device self-destruct at the end of the procedure?". 
 Avoidance of wound dehiscence: “Clip-&-Wear” clamps with an exceptionally narrow 
clamping ring can bring about wound dehiscence, especially when the circumcision 
style is tight such that the shaft skin is significantly stretched. What was intended 
merely to grip takes on the potential to cut, doing so proximally to the intended scar 
line and thus forcing remedial action that results in a tighter circumcision than 
originally envisaged. This problem appears to be age-related and gives rise to some 
criticism of the widespread use of ischaemic necrosis techniques in adults (Vernon 
Quaintance, The Gilgal Society, personal communication). There may be good cause for 
separating out older sexually-active adults and providing them with conventional 
surgery. Local factors appear to intrude here, especially nutritional status, a well-known 
determinant of wound healing capacity. 
 Even and adequate clamping pressure: Devices using the process of ischaemic necrosis 
need to apply their strangulation pressure evenly right around the intended scar line. 
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Unless effective counter-measures are taken, pressure discontinuities can arise, 
especially at hinge positions and/or latch positions. This gives rise to the possibility of 
continued marginal blood flow at these points. In terms of infection, such marginal 
leaking is exceptionally dangerous. A good design for an ischaemic necrosis clamp is 
one that has no discontinuity in the clamping ring and which, throughout the wear 
period, maintains an absolutely even pressure sufficient to bring about total cessation of 
blood flow across the whole of the intended scar line. 
 Resistance to premature removal by a meddlesome patient: Premature removal of an 
ischaemic necrosis clamp can precipitate a clinical emergency. Therefore it is vital that 
the latching mechanism of the clamp should be secure against tampering. The risk of 
such tampering is greatest when dealing with post-infancy paediatric patients. 
 Minimum requirement for pre-treatment: In the world of veterinary medicine, 
immunization against tetanus is recommended when ischaemic necrosis is used for 
procedures such as tail docking of lambs by means of the Elastrator device (Thedford, 
1983). We commend the idea of similar pre-treatment before any ischaemic necrosis 
procedure is used for MC. 
 Cultural acceptability: A whole raft of issues can arise here, any one of which might 
scupper a proposal to use a particular design of clamp in a particular area. For example, 
is a device invented in Israel assured of acceptance in Islamic Republics that do not 
even acknowledge the existence of the Jewish state? Will circumcision ever be accepted 
by Hindus, many of whom value their foreskins as evidence of not being Muslim? 
During the partition of India in 1947, strangers suspected of being of the opposite faith 
were disrobed and put to death on no more evidence than their circumcision status 
(Kamra, 2002). Rather less dramatically, there is the question of whether a clip-&-wear 
clamp protrudes beyond the end of the penis during the wear period. Not a problem in 
societies where loose, flowing robes are normal attire, but an entirely different matter 
when the male is habitually dressed in tight jeans. 
10. Resulting new designs for circumcision devices 
The authors are aware of eight products designed to fulfil the demand for a field-use device, 
all being either in full production or in the final stages of development and testing. These are 
now considered individually, in alphabetical order of trade name. Only the original patents 
or patent applications in the inventor's country of residence are listed; increments may exist in 
the same country as well as there being patents elsewhere. 
It should be noted that some clamps have been the subject of ongoing development after 
their initial market launch. Care is needed when reading reports of field trial results. Early 
criticisms may have been rendered obsolete by subsequent design changes. 
10.1 AccuCirc 
Inventor:  Tomlinson, D.R. 
Primary patent:  US2005/022404 
Patent priority date: 25 Jun 2004 
Patient age range: Full-term neonate only 
Website:   http://www.accucirc.com 
Category:  Automated cutter 
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Fig. 9. The AccuCirc device. 
Procedure: The AccuCirc uses two innovative components, a Foreskin Probe/Shielding Ring 
that ensures the glans is protected with the foreskin properly aligned and a Single-Action 
Clamp that ensures adequate haemostasis and the precise delivery of the protected, circular 
blade. These work together to protect the infant from injury. This device simplifies the 
circumcision procedure and eliminates the need for a dorsal slit, as well as removing 
potential for mismatching of parts. It comes in a self-contained kit. This is completely 
disposable and no part is retained on the infant. 
10.2 Ali's Klamp 
Inventor:  Canoğlu, V.A.  
Primary patent:   TR2003/00403 
Patent priority date: 28 Mar 2003 
Patient age range: Full-term neonate to adult (experimental in adult sizes) 
Website:   http://www.alisklamp.com 
Category:  Ischaemic necrosis device 
 
 
Fig. 10. Ali’s clamp. 
Procedure: The Ali's Klamp (a.k.a. “Alisklamp” and “Ali’s clamp”; Telif Haklari ABAGROUP 
Ltd) is a single-use ischaemic necrosis device; the foreskin is crushed between two plastic 
surfaces. The recommended procedure includes severing of the excess tissue. During that 
process, the tube protects the glans from accidental injury. Note that the final scar line forms 
at the position of the clamping ring, not at the position of the scalpel cut. In theory the user 
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could dispense with the scalpel cut, leaving the whole foreskin to necrotise. The procedure 
is illustrated in a two-part video available on the manufacturer's website. 
The Ali's Klamp differs from the SmartKlamp (below) only in one significant respect: The 
clamping ring is angled to match the typical slant of the coronal rim of the glans. In theory 
this achieves better capture of inner foreskin ventrally. The Ali's clamp apparently shares 
with the SmartKlamp one notable design weakness. An unwilling or meddlesome patient 
could, in theory, open the clamp by placing a flat object such as a table knife between the 
tube and the locking arms and then twisting. Additionally, such action would render the 
device liable to unscrupulous re-use several times over, until such time as the nominally 
single-use latching mechanism wore out. 
A review of 7,500 boys who underwent circumcision with this device under local anaesthesia 
concluded that cosmetic appearance was better than conventional circumcision of 5,700 boys 
(Senel et al., 2010). Duration was 4.5 ± 1.5 minutes versus 23 ± 4 minutes, respectively. 
Complications were seen in 2% of Ali’s clamp versus 10.4% for conventional circumcision, the 
most common for the Ali’s clamp being buried penis (1.04%), followed by infection (0.6%), 
bleeding (0.4%). A mass circumcision of 2,013 male infants, children, adolescents and adults 
(mean age 7.8 ± 2.5 years) over a 7-day period, noted a duration of 3.6 ± 1.2 minutes and 
complication rate of 2.93% in those < 2 years of age, mostly from buried penis (0.98%) and 
excessive foreskin (0.98%) (Senel et al., 2011). In older children, adolescents and adults 
complication rate was 2.39%, 2.51% and 2.40%, respectively. Overall, excessive foreskin (0.7%) 
was ther most common complication, followed by bleeding (0.60%), infection (0.55%), wound 
dehiscence (0.25%), buried penis (0.25%), and urine retention (0.10%). There was no effect on 
erectile function and libido, and a 96% satisfaction rate was recorded. 
Originally available only for children, adult sizes reportedly now exist for use on a trial basis. 
Correspondence received mid-February 2011 from Dr. Ali Canoğlu claims a successful field 
trial in Africa. At the time of writing official independent reports have not yet been published. 
10.3 Ismail Klamp 
Inventor:  Salleh, I. 
Primary patent:   MY2008/000195 
Patent priority date: 16 Jan 2008 
Patient age range: Full-term neonate to puberty 
Website:   http://www.ismailclamp.com/ 
Category:  Ischaemic necrosis device 
 
 
Fig. 11. The Ismail Klamp. 
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Procedure: The Ismail Klamp is another single-use ischaemic necrosis device, functioning in 
the same way as the Ali's Klamp, SmartKlamp and Tara KLamp. The distinguishing feature 
of Dr. Ismail Salleh's device is that the clamping ring can be loosened as well as tightened 
during the process of application. This the manufacturer describes as "Reversible 
Clamping". Such a feature is undoubtedly an advantage if a tight style of circumcision is 
required; it gives greater scope for clamp adjustment. Against that advantage must be offset 
two risks: A meddlesome patient might loosen the clamp during the healing period and the 
clamp might be re-used unscrupulously. 
10.4 PrePex 
Inventors:  Fuerst, O., Kilemnick, I. and Shohat, S.  
Primary patent:   (Application:) IL2010/000568 
Patent priority date: 16 Jul 2009 
Patient age range: Adult only at present 
Website:   http://www.prepex.com/ 
Category:  Ischaemic necrosis device 
 
 
Fig. 12. The PrePex device. (Photo supplied by Circ MedTech ©2011) 
Developed in 2009/10 by Dr. Oren and Tzameret Fuerst, Ido Kilemnick & Shaul Shohat 
(Fuerst et al., 2009) and marketed by a company called Circ MedTech Limited (incorporated 
in the British Virgin Islands), this device is designed for use in non-sterile environments by 
minimally trained healthcare professionals. 
Possibly unique for modern clamps, publicized abstracts of safety and efficacy trials held in 
Rwanda found it to be suitable for use without anaesthesia. Four hundred milligrams of oral 
Brufen is routinely offered 30 minutes after placement of the clamp, but no other drug use is 
involved. Whilst the surplus foreskin can be severed, in these trials the foreskin was left to 
necrotize intact thus facilitating a quick and bloodless procedure that can be handled by 
minimally trained healthcare professionals in non-sterile settings. The company affirms that 
there have been no complications to the urine stream as a result of the necrotized foreskin 
being left in situ. 
In common with other ischaemic necrosis clamps, the PrePex device requires no sutures. 
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Procedure: After sizing and marking of the circumcision line based on the circumcision style 
desired (high/low), the Elastic Ring, loaded on to the Delivery Ring, is placed at “deploy-
ready” position on the penis base (proximal). The foreskin tip is stretched open to allow 
insertion of the Inner Ring, directly under the coronal sulcus.  The Elastic Ring is then 
deployed within the Inner Ring groove, initiating the ischaemic process and the Delivery 
Ring is removed. The patient resumes his activities with only the Elastic Ring visible. After 7 
days, the device is removed by flicking the Elastic Ring out of the groove and extracting the 
inner ring with fingers or a standard medical spatula. 
Regulatory issues (as declared by the manufacturer): "The device has a CE mark and is 
manufactured using USP Class VI biocompatible elastomeric materials compliant to 
ISO_13485 Medical Devices (Quality Management systems) and FDA, 21_CFR177.2600." 
Declared contra-indication: The device is contraindicated for patients with phimosis if the 
chosen procedure leaves the foreskin intact.  
Once evidence of the style of circumcision achieved by this device is made public, this 
latecomer to the design contest is expected to show significant advantages over its 
competitors – especially if the claim of suitability for routine use without anaesthesia is 
validated in more extensive trials. 
10.5 Shang Ring 
Inventor:  Shang, J. 
Primary patent:   CN2003/000903 
Patent priority date: 20 Oct 2003 
Patient age range: Full-term neonate to adult 
Website:   http://www.snnda.com/enindex.asp 
Category:  Ischaemic necrosis device 
 
 
Fig. 13. The Shang Ring device. 
Procedure: The "Shenghuan Disposable Minimally Invasive Circumcision Anastomosis 
Device", developed in China by Jianzhong Shang, involves minimal tissue manipulation and 
is said to give a simpler, quicker and safer circumcision than conventional techniques 
(Masson et al., 2010). It consists of two concentric plastic rings that sandwich the foreskin of 
the penis, allowing circumcision without stitches or notable bleeding. As well as 
substantially reduced operating times, MC using this device is associated with a low 
complication rate, and the technique can easily be taught to both physicians and non-
physicians. The Shang Ring is produced by Wuhu Snnda Medical Treatment Appliance 
Technology Co. Ltd, Wuhu City, China. 
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When tested on 1,200 patients aged 5 to 95 years operating time was 2.5 minutes for patients 
with excessive foreskin and 3.5 minutes for those with phimosis (Peng et al., 2008).  After 
application it is worn for a week, with no incidents of device dislocation or damage to the 
frenulum. Peng et al. describe the use of oral diethylstilbestrol (at a dosage of 2 mg/night) as 
a way to prevent nocturnal erections during the wear period. We do not find favour with 
this, due to the known environmental persistence of DES and the long-term effects of this 
synthetic oestrogen (Newbold et al., 2006). In this study by Peng et al. the incision healed in 
96.3%, leaving minimal inner foreskin, with no scarring and good cosmetic results. 
Antibiotics were not used, and only 0.67% got an infection. After removal, of the device 
0.58% had some minimal bleeding around the incision and 2.4% had wound dehiscence of 
the incision caused by nocturnal erection, but this could be prevented by continuation of 
diethylstilbestrol for 3 days. It was treated by simply closing the incised rim with a butterfly 
adhesive plaster, followed by topical disinfectant; no stitches were required. Patients 
reported less pain than occurs for conventional methods. 
Use of the Shang Ring has become a method of choice in the People's Republic of China. 
Evaluation of a standardized surgical protocol for its use, involving 328 men, showed an 
operating time of 4.7 ± 1.3 minutes, pain scores of 0.2 ± 0.6 during the surgery, 1.6 ± 1.0 24 
hours postoperatively, 1.7 ± 1.1 twenty four hours prior to ring removal, and 2.7 ± 1.4 during 
ring removal (Cheng et al., 2009). In this study, complications included infection in 0.6%, 
bleeding in 0.6% and wound dehiscence in 0.6%; none of the latter required suturing. Penile 
oedema occurred in 4.9%. The time for complete wound healing was 20.3 ± 6.7 days. 
Satisfaction was 99.7%. 
A study in 824 boys with phimosis or redundant foreskin found duration was 2.6 ± 1.2 
minutes (Yan et al., 2010). Wounds healed and rings were removed at 13.4 ± 5.8 days 
revealing a well-smoothed incision and good cosmetic results. Complications were low and 
included infection in 0.6%, oedema in 3.2%, delayed removal of the ring in 1.5%, and 
redundant and asymmetric mucosa attributable to performance in 0.9%. 
Another study in China, of 402 patients, found duration (4.7 ± 1.3) minutes, blood loss (2.6 ± 
1.8 ml), and postoperative satisfaction (99.5%) for Shang Ring circumcision were 
significantly better than conventional circumcision, and International Index of Erectile 
Dysfunction (IIEF-5; not “IIRF-5” as stated in the paper) was no different (Li et al., 2010). In 
351 males aged 4 to 58 (mean 31) circumcised for phimosis or redundant foreskin using the 
Shang Ring, infection was seen in 1.4%, mild oedema in 2.6%, moderate oedema in 1.4%, 
and wound dishescence in 1.7%, with no postoperative bleeding being observed (Peng et al., 
2010b). 
A proof of concept study in Kenya for the roll-out of MC for HIV prevention found a time of 
4.8 ± 2.0 minutes for the procedure and 3.9 ± 2.6 minutes for device removal, with 6 mild 
adverse events in the 40 men who underwent Shang Ring circumcision (Barone et al., 2011). 
These included 3 penile skin injuries, 2 cases of oedema and one infection, all of which 
resolved with conservative management. Partial ring detachment occurred in 3 between 
days 2 to 7, none of which required treatment or ring removal. Erections with the ring were 
well tolerated. By day 2, eighty percent of the men had returned to work, and at 42 days all 
said they were very satisfied with their circumcision and would recommend it to others. 
Aside from the matter of diethylstilbestrol use, without which there appears to be a danger 
of an erection displacing the device, possible further criticisms relate to the discontinuity of 
the clamping ring at both the hinge and clasp. It should also be noted that it gives no 
protection whatsoever to the glans during the severing of the prepuce. 
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The same inventor has also obtained a patent in respect of another, more recent but very 
different design. The relevant patent is CN2009/000406. It is unclear whether the later 
design is intended to supersede the original, or compete with it. 
10.6 SmartKlamp 
Inventor:  Ten Have, H.F. 
Primary patent:   MY0100375 
Patent priority date: 30 Jan 2001 
Patient age range: Full-term neonate to mid-puberty 
Website:   http://smartcircumcision.com/index.html 
Category:  Ischaemic necrosis device 
 
 
Fig. 14. The SmartKlamp. 
Procedure: The SmartKlamp is an ischaemic necrosis device functioning in broadly the same 
way as the Ali's Klamp, Ismail Klamp and Tara KLamp. 
Since its invention by Henri Ferdinand Ten Have, the commercial history of the 
SmartKlamp has to some extent interfered with its development and availability. Originally 
produced only in child sizes by the Dutch company Circumvent BV (Hengelo, The 
Netherlands), supply ceased when Circumvent BV went into liquidation, having apparently 
over-spent on research and development of the adult model. It should perhaps be noted that 
Circumvent's experimental adult device had an angled clamping ring similar in principle to 
that now found in the Ali's Klamp. 
The apparently identical product in child sizes has now appeared in Malaysia, marketed by 
a supplier called Smartcircumcision. Aldemir and co-workers described the device thus: 
"This fits on the penis much as the others do. After 4 days the connection between its inner 
tube and casing is cut and removed. The inner tube is then left to fall off spontaneously in 
time. Median operative time is 8 minutes, compared with 18 minutes for conventional 
dissection, and cosmetic result, judged blinded by a urologist, was better. Parents' 
satisfaction scores were the same" (Aldemir et al., 2008). 
The SmartKlamp differs from the Ali's Klamp only in one significant respect: The clamping 
ring is not angled to match the typical slant of the coronal rim of the glans. In theory this 
achieves less satisfactory capture of inner foreskin ventrally, but the original manufacturer 
claimed it is possible to adjust the foreskin to compensate. The SmartKlamp apparently 
shares with the Ali's Klamp one notable design weakness. An unwilling or meddlesome 
patient could, in theory, open the clamp by placing a flat object such as a table knife between 
the tube and the locking arms and then twisting. Additionally, such action would render the 
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device liable to unscrupulous reuse several times over, until such time as the nominally 
single-use latching mechanism wore out. 
A training video is available for purchase from the current supplier's website. 
10.7 Sunathrone 
Inventor:   Surat, T.b. 
Primary patent:  (Application:) MY2006/000281 
Patent priority date: 23 Jan 2006 
Patient age range: Full-term neonate to adult 
Website:   http://www.sunathrone.com/ 
Category:  Ischaemic necrosis device 
 
 
Fig. 15. The Sunathrone device. 
Procedure: The Sunathrone clamp differs markedly from the other ischaemic necrosis devices 
considered here, in that the crushing action is achieved by means of a wrap-around "cuff" 
rather than concentric rings. Nominally this introduces a problem of pressure discontinuity 
at the hinge and latch, but Dr. Tasron bin Surat's design overcomes that by means of springy 
cuff extensions that bridge these gaps. 
In order to achieve sufficient pressure between the cuff and the tube, a special tool called a 
"Sunalever" is required to close the Sunathrone clamp. This is a large item, sized according 
to the device being applied to the patient. It can be seen in use on the web page 
http://www.circlist.com/instrstechs/sunathrone.html. In the absence of on-site 
sterilization facilities, one Sunalever would have to be packaged with each clamp. This has 
implications in terms of cost, package size and waste disposal. 
Two points in favour of this design are that the latching mechanism is highly tamper-
resistant and, once the bayonet joint of the tube (ringed in yellow in the image above) is 
unplugged, nothing protrudes beyond the tip of the glans. The manufacturers claim 
suitability for use in cases of buried penis, the relatively large diameter of the cuff 
preventing the glans from withdrawing into the abdomen and forming adhesions during 
the healing period. 
10.8 Tara KLamp 
Inventor:   Singh, G.S.T. 
Primary patent:   US5649933 
Patent priority date: 20 Apr 1992 
Patient age range: Full-term neonate to adult 
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Website:   Tara Medic does not have its own website. See instead:  
   http://www.circlist.com/instrstechs/taraklamp.html 
Category:  Ischaemic necrosis device 
 
 
Fig. 16. The Tara KLamp. 
Procedure: The Tara KLamp is the original single-use “clip-&-wear” ischaemic necrosis 
device to have gone into commercial production. Procedure for use is substantially the same 
as for the Ali's Klamp, Ismail Klamp and SmartKlamp. Since its invention nearly 20 years 
ago by Gurchran Singh Tara Singh, the Tara KLamp has undergone a number of design 
changes the most notable of which relates to its size, which has reduced considerably, thus 
making the current version more convenient to wear than the original. 
The latching mechanism of the Tara KLamp is especially secure, making this design suitable 
for use on unwilling, meddlesome or autistic boys. 
Considerable criticism of the Tara KLamp has arisen in consequence of a paper published by 
Lagarde and associates (Lagarde et al., 2009). The authors of the present chapter are in 
possession of documentary evidence apparently proving that Lagarde's team did not attend 
Tara Medic's training course relating to use of the Tara KLamp. Furthermore, these 
documents also appear to show that Lagarde's team departed from the procedure set down 
in the package insert. If true, we suggest the resulting criticism of the Tara KLamp to be 
unfair and possibly unwarranted. Unpublished studies by the Health Department of 
KwaZulu-Natal apparently failed to replicate the problems and the Tara KLamp has now 
been accepted as the “preferred device” for use in Kwa-Zulu Natal. 
We suggest that, at the very least, Lagarde's findings should be set aside pending further 
investigation. Safety and efficacy trials of the Tara KLamp should be repeated by a different 
team. Such a trial might usefully address one further issue: Whether or not the Tara KLamp 
can be successfully used without the foreskin being severed, instead leaving it to necrotise in 
situ as is done with the PrePex device. 
11. World Health Organisation’s preference?  
Early in 2011 the World Health Organisation formed a Technical Advisory Group (TAG) 
with a remit to look at evidence and make recommendations to WHO regarding choice of 
circumcision clamp, but to date the TAG has not published any recommendations (Personal 
correspondence between co-author C. Eley and the co-Chairman on 21 Feb 2011). It is to be 
hoped that, when they do, it will be a shortlist for local consideration rather than a 
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recommendation favouring one particular device globally. It is the considered opinion of the 
present authors that it would be inappropriate for there to be a single winner in this contest. 
The best clamp in any given situation is likely to be a function of local factors. 
12. Conclusions 
MC can be performed at any age, but infancy is the ideal time for reasons of safety, 
procedural simplicity, convenience, minimal risk and cost (Wiswell & Geschke, 1989; 
Wiswell & Hachey, 1993; Wiswell, 1995; Wiswell, 1997; Wiswell, 2000). The benefits in 
respect of UTIs and penile cancer are, moreover, maximized if circumcision takes place in 
infancy. Circumcising prior to onset of sexual activity rather than later also means a 
completely healed penis, so that risk of infection, such as by HIV, during the healing period 
is reduced.  
Thus the present campaigns to circumcise adults should be seen as a mere catching-up 
exercise, making good past omissions to circumcise pre-puberty. The ultimate aim should be 
to make infant MC a global norm, the health rewards being too great to overlook (Morris, 
2007; World Health Organisation, 2007a,b; Tobian et al., 2009; Cooper et al., 2010). 
MC has no long-term adverse consequences (Morris, 2007; Smith et al., 2010; Tobian et al., 
2010). Good quality research studies that include thermal imaging show similar sensation 
during arousal for the circumcised and uncircumcised penis (Payne et al., 2007). The lack of 
any diminution in sexual function, satisfaction or sensation is now backed up by evidence 
from large RCTs (Bailey et al., 2007; Krieger et al., 2008). In fact 64% of the men in one of the 
trials reported an increase in their penile sensitivity and 54% reported greater ease in 
reaching orgasm (Krieger et al., 2008). This did not mean an increase in premature 
ejaculation. The fact that circumcision does not impair, and for many may enhance, a man’s 
sensation and sexual pleasure, should reassure men considering whether to get circumcised 
(Sharlip, 2008). MC is preferred by most women for reasons of hygiene, sexual activity, 
reduced STI risk, and greater enjoyment of intercourse (Williamson & Williamson, 1988; 
Badger, 1989a,b; Moses et al., 1998; Nnko et al., 2001; Kigozi et al., 2009a). 
Biomedical engineering clearly has its place in delivering MC, despite the existence of 
methods and traditions that are many thousands of years old. Recent progress in 
instrumentation design has resulted in devices that have begun to address the need for 
circumcisions that are quick, safe and convenient, and that can be used in “field” settings. 
Such advances in biomedical engineering are essential in ensuring a safe and practical way 
of dealing with the numbers of males of all ages in the modern world who need to be 
circumcised. 
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